Clik here to view.
イルミナとマイクローバ・ライフ・サイエンシズが微生物叢研究を加速化すべく提携
豪メルボルン （ビジネスワイヤ） — DNAシーケンシングおよびアレイベース技術の世界的リーダー企業であるイルミナは本日、ヒトの健康と疾患にかかわるヒト腸内微生物叢の理解を深めるため、精密腸内微生物叢科学のリーダー企業であるマイクローバ・ライフ・サイエンシズと提携したと発表しました。...
View ArticleClik here to view.
Prime Healthcare Sending Humanitarian Aid and Life Saving COVID-19 Relief to...
ONTARIO, Calif. In response to an overwhelming surge of COVID-19 cases in India, Prime Healthcare committed to send desperately needed humanitarian aid, medical equipment and supplies for immediate...
View ArticleClik here to view.
长期安全性和有效性结果凸显武田登革热候选疫苗的潜在影响力
日本大阪和马萨诸塞州剑桥 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（“武田”）今天宣布，进行中的关键性3期四价免疫抗登革热有效性研究(Tetravalent Immunization against Dengue Efficacy Study,...
View ArticleClik here to view.
New Frontier Health Corporation Receives NYSE Notice Regarding Late Form 20-F...
BEIJING New Frontier Health Corporation (NYSE: NFH) today announced that, as expected, on May 18, 2021 it received a notice from the New York Stock Exchange (the “NYSE”) that the Company was not in...
View ArticleClik here to view.
Vocera Announces Distribution Agreement with Wavelink in Australia
SAN JOSE, Calif. Vocera Communications, Inc. (NYSE:VCRA), a recognised leader in clinical communication and workflow solutions, today announced a distribution agreement with Wavelink, a leader in...
View ArticleClik here to view.
Oral-B Encourages Consumers to Brush up on Their Oral Care Regimen and...
LONDON Oral-B has teamed up with Scientific American and its Custom Media Division (SACM) to explore the latest research connecting oral health and overall health; as many are unaware of the impact...
View ArticleClik here to view.
Orum Therapeutics Appoints Jae Won Kim Chief Financial Officer
BOSTON & DAEJEON, South Korea Orum Therapeutics, a global biotech company pioneering the development technologies for precision delivery of targeted protein degraders to treat cancer, today...
View ArticleClik here to view.
BIO KOREA 2021 International Convention to Unlock the Secret of Future...
SEOUL, South Korea As one of the most important global bio-health conventions, BIO KOREA 2021 International Convention has garnered great attention from home and abroad. To facilitate the discussion...
View ArticleClik here to view.
Rapid Medical宣布完成5,000万美元的D轮融资
以色列约克尼穆 (美国商业资讯)–专注于开发响应式、可调节神经血管手术器械的公司Rapid Medical今天宣布，公司已完成5,000万美元的D轮融资并获超额认购。所得资金将用于支持公司的微创卒中治疗产品在全球的快速商业扩张。本轮融资由MicroPort领投，中信产业基金(CPE)、Deep Insight和现有投资者参投。 Rapid...
View ArticleClik here to view.
CORRECTING AND REPLACING Oral-B & Crest Encourage Consumers to Brush up on...
LONDON Please replace the release with the following corrected version due to multiple revisions. The updated release reads: ORAL-B & CREST ENCOURAGE CONSUMERS TO BRUSH UP ON THEIR ORAL CARE...
View ArticleClik here to view.
BIO KOREA 2021国際大会、未来のテクノロジーの秘密を解き明かす
韓国ソウル （ビジネスワイヤ） — 最も重要な世界的バイオヘルス大会の1つとして、BIO KOREA 2021国際大会は国内外から大きな注目を集めています。「COVID-19時代」における未来のバイオヘルス産業に関する議論を促進するために、6月9日から21日まで開催されるBIO KOREA 2021は、「ニューノーマル：バイオ・イノベーションで障壁を打ち破る」をテーマに展開されます。 BIO...
View ArticleClik here to view.
BIO KOREA 2021国际生物技术展解锁未来技术秘密
韩国首尔 (美国商业资讯)–作为全球极为重要的生物健康展会之一，BIO KOREA 2021国际生物技术展备受国内外关注。为促进对“COVID-19时代”未来生物健康产业的讨论，将于6月9日至21日举行的BIO KOREA 2021将围绕“新常态：通过生物创新突破壁垒”(New Normal: Breaking Barriers with Bio Innovation)这一主题展开。 BIO...
View ArticleClik here to view.
武田薬品のデング熱ワクチン候補が持つ潜在力が長期の安全性および有効性を検討した試験の結果により強化
大阪 & 米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:4502/NYSE:TAK）（「武田薬品」）は本日、当社のデング熱ワクチン候補（TAK-003）が、進行中のピボタル第3相「デング熱に対する4価ワクチン予防接種の有効性試験」（Tetravalent Immunization against Dengue Efficacy...
View ArticleClik here to view.
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution...
MELBOURNE, Australia Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations...
View ArticleClik here to view.
CDISC Teams Up with Microsoft to Develop Open-Source Software for the...
AUSTIN, Texas CDISC is teaming up with Microsoft to develop the CDISC Open Rules Engine (CORE), open-source software that executes machine-readable CDISC Conformance Rules. The global clinical...
View ArticleClik here to view.
HighTide Announces First Patient Dosed in Phase 2 PRONTO-PBC Clinical Study...
SHENZHEN, China & ROCKVILLE, Md. HighTide Therapeutics (“HighTide”), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for non-viral chronic liver...
View ArticleClik here to view.
Benefits in a Pandemic: NaturalVue® Offers Multiple Solutions for Patients...
ATLANTA US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses (‘NaturalVue MF’) Visioneering Technologies, Inc (ASX: VTI) (‘Visioneering’,...
View ArticleClik here to view.
Sesen Bio Announces Global Supply Partnership with Qilu Pharmaceutical
CAMBRIDGE, Mass. Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that on Tuesday,...
View ArticleClik here to view.
The First Million: American India Foundation Launches Its Vaccination...
NEW DELHI The American India Foundation (AIF) announced the launch of its vaccination campaign, The First Million, an effort to ensure vaccination for a million of the most vulnerable and...
View ArticleClik here to view.
Preclinical Studies From Vaxxas and Collaborators Reveal Potential of Vaxxas’...
CAMBRIDGE, Mass. & BRISBANE, Australia Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced that research demonstrating the potential of...
View Article